304 related articles for article (PubMed ID: 19234571)
21. Heterogeneous expression of potassium currents and pacemaker currents potentially regulates arrhythmogenesis of pulmonary vein cardiomyocytes.
Chen YC; Pan NH; Cheng CC; Higa S; Chen YJ; Chen SA
J Cardiovasc Electrophysiol; 2009 Sep; 20(9):1039-45. PubMed ID: 19473300
[TBL] [Abstract][Full Text] [Related]
22. [Ion channels and arrhythmias].
Borchard U; Hafner D
Z Kardiol; 2000; 89 Suppl 3():6-12. PubMed ID: 10810780
[TBL] [Abstract][Full Text] [Related]
23. Modulation of spiral wave reentry by K(+) channel blockade.
Honjo H; Yamazaki M; Kamiya K; Kodama I
Circ J; 2007; 71 Suppl A():A26-31. PubMed ID: 17587736
[TBL] [Abstract][Full Text] [Related]
24. Hyperpolarization-activated cyclic nucleotide-gated channels and T-type calcium channels confer automaticity of embryonic stem cell-derived cardiomyocytes.
Yanagi K; Takano M; Narazaki G; Uosaki H; Hoshino T; Ishii T; Misaki T; Yamashita JK
Stem Cells; 2007 Nov; 25(11):2712-9. PubMed ID: 17656646
[TBL] [Abstract][Full Text] [Related]
25. Molecular composition and functional properties of f-channels in murine embryonic stem cell-derived pacemaker cells.
Barbuti A; Crespi A; Capilupo D; Mazzocchi N; Baruscotti M; DiFrancesco D
J Mol Cell Cardiol; 2009 Mar; 46(3):343-51. PubMed ID: 19135060
[TBL] [Abstract][Full Text] [Related]
26. Putting the pacemaker channel through its paces to build a better biological pacemaker.
Accili E
J Physiol; 2009 Apr; 587(Pt 7):1381-2. PubMed ID: 19336609
[No Abstract] [Full Text] [Related]
27. Cardiac arrhythmogenesis: a tale of two clocks?
Lei M; Huang CL
Cardiovasc Res; 2020 Dec; 116(14):e205-e209. PubMed ID: 31800017
[No Abstract] [Full Text] [Related]
28. Transient outward potassium channel regulation in healthy and diabetic hearts.
Gallego M; Alday A; Urrutia J; Casis O
Can J Physiol Pharmacol; 2009 Feb; 87(2):77-83. PubMed ID: 19234570
[TBL] [Abstract][Full Text] [Related]
29. Repolarization gradients and arrhythmogenicity in the murine heart.
Killeen MJ; Sabir IN
J Physiol; 2007 Sep; 583(Pt 2):419-20. PubMed ID: 17627980
[No Abstract] [Full Text] [Related]
30. Cardiac potassium channel subtypes: new roles in repolarization and arrhythmia.
Schmitt N; Grunnet M; Olesen SP
Physiol Rev; 2014 Apr; 94(2):609-53. PubMed ID: 24692356
[TBL] [Abstract][Full Text] [Related]
31. Management of cocaine-induced cardiac arrhythmias due to cardiac ion channel dysfunction.
Wood DM; Dargan PI; Hoffman RS
Clin Toxicol (Phila); 2009 Jan; 47(1):14-23. PubMed ID: 18815938
[TBL] [Abstract][Full Text] [Related]
32. The role of microRNA in cardiac excitability.
Wang Z
J Cardiovasc Pharmacol; 2010 Nov; 56(5):460-70. PubMed ID: 20588186
[TBL] [Abstract][Full Text] [Related]
33. [Current concepts of the ionic mechanisms of cardiac arrhythmias and the possible mechanisms of action of cardiac anti-arrhythmia agents].
Porotikov VI; Lazarev AV; Glezer GA
Usp Fiziol Nauk; 1984; 15(3):42-63. PubMed ID: 6089463
[No Abstract] [Full Text] [Related]
34. Effects of cilostazol in the heart.
Kanlop N; Chattipakorn S; Chattipakorn N
J Cardiovasc Med (Hagerstown); 2011 Feb; 12(2):88-95. PubMed ID: 21200326
[TBL] [Abstract][Full Text] [Related]
35. Mapping arrhythmias in the failing heart: from Langendorff to patient.
Akar JG; Akar FG
J Electrocardiol; 2006 Oct; 39(4 Suppl):S19-23. PubMed ID: 16920143
[TBL] [Abstract][Full Text] [Related]
36. New therapeutic targets in cardiology: heart failure and arrhythmia: HCN channels.
Roubille F; Tardif JC
Circulation; 2013 May; 127(19):1986-96. PubMed ID: 23671179
[No Abstract] [Full Text] [Related]
37. Mechanisms of disease: ion channel remodeling in the failing ventricle.
Nass RD; Aiba T; Tomaselli GF; Akar FG
Nat Clin Pract Cardiovasc Med; 2008 Apr; 5(4):196-207. PubMed ID: 18317475
[TBL] [Abstract][Full Text] [Related]
38. Role of potassium currents in cardiac arrhythmias.
Ravens U; Cerbai E
Europace; 2008 Oct; 10(10):1133-7. PubMed ID: 18653669
[TBL] [Abstract][Full Text] [Related]
39. Engineering physiologically controlled pacemaker cells with lentiviral HCN4 gene transfer.
Boink GJ; Verkerk AO; van Amersfoorth SC; Tasseron SJ; van der Rijt R; Bakker D; Linnenbank AC; van der Meulen J; de Bakker JM; Seppen J; Tan HL
J Gene Med; 2008 May; 10(5):487-97. PubMed ID: 18383475
[TBL] [Abstract][Full Text] [Related]
40. Glibenclamide attenuates the antiarrhythmic effect of endotoxin with a mechanism not involving K(ATP) channels.
Iskit AB; Erkent U; Ertunc M; Guc MO; Ilhan M; Onur R
Vascul Pharmacol; 2007 Feb; 46(2):129-36. PubMed ID: 17064967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
